Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Marignier

Showing results (11-20 of 215) with videos related to

Pageof 22
Sort By:
Neurology|May 5, 2025
Increased Risk of Misdiagnosis and Treatment Complication in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseRomain Marignier, Yael Hacohen
Developmental Medicine and Child Neurology|October 9, 2019
Myelin oligodendrocyte glycoprotein antibodies associated disease: how important are B cells?Yael Hacohen, Romain Marignier
Presse Medicale (Paris, France : 1983)|December 24, 2014
[Evolution of Devic's neuromyelitis optica spectrum disorders]Raphaël Bernard-Valnet, Romain Marignier
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2024
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: NoRomain Marignier, Bruce Ac Cree
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 18, 2019
MOG-antibody-associated disease is different from MS and NMO and should be considered as a distinct disease entity - NoAlvaro Cobo-Calvo, Romain Marignier
Multiple Sclerosis and Related Disorders|March 19, 2022
The frequent sign of a rare disease or the rare sign of a frequent disease?Romain Deschamps, Jerome Lambert, Romain Marignier
Clinical Neurology and Neurosurgery|September 6, 2025
Role for long term treatment in NMOSD induced by the immune checkpoint inhibitor cemiplimabFien Oelbrandt, Romain Marignier, Bénédicte Dubois
Current Opinion in Neurology|March 18, 2024
Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodiesElisabeth Maillart, Kumaran Deiva, Romain Marignier
Current Opinion in Neurology|March 18, 2017
Neuromyelitis optica and neuromyelitis optica spectrum disordersRomain Marignier, Alvaro Cobo Calvo, Sandra Vukusic
Current Opinion in Neurology|February 15, 2019
Clinical spectrum of central nervous system myelin oligodendrocyte glycoprotein autoimmunity in adultsAlvaro Cobo-Calvo, Sandra Vukusic, Romain Marignier
Pageof 22

Showing results (11-20 of 215) with videos related to

Sort By:
Pageof 22
Neurology|May 5, 2025
Increased Risk of Misdiagnosis and Treatment Complication in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseRomain Marignier, Yael Hacohen
Developmental Medicine and Child Neurology|October 9, 2019
Myelin oligodendrocyte glycoprotein antibodies associated disease: how important are B cells?Yael Hacohen, Romain Marignier
Presse Medicale (Paris, France : 1983)|December 24, 2014
[Evolution of Devic's neuromyelitis optica spectrum disorders]Raphaël Bernard-Valnet, Romain Marignier
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2024
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: NoRomain Marignier, Bruce Ac Cree
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 18, 2019
MOG-antibody-associated disease is different from MS and NMO and should be considered as a distinct disease entity - NoAlvaro Cobo-Calvo, Romain Marignier
Multiple Sclerosis and Related Disorders|March 19, 2022
The frequent sign of a rare disease or the rare sign of a frequent disease?Romain Deschamps, Jerome Lambert, Romain Marignier
Clinical Neurology and Neurosurgery|September 6, 2025
Role for long term treatment in NMOSD induced by the immune checkpoint inhibitor cemiplimabFien Oelbrandt, Romain Marignier, Bénédicte Dubois
Current Opinion in Neurology|March 18, 2024
Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodiesElisabeth Maillart, Kumaran Deiva, Romain Marignier
Current Opinion in Neurology|March 18, 2017
Neuromyelitis optica and neuromyelitis optica spectrum disordersRomain Marignier, Alvaro Cobo Calvo, Sandra Vukusic
Current Opinion in Neurology|February 15, 2019
Clinical spectrum of central nervous system myelin oligodendrocyte glycoprotein autoimmunity in adultsAlvaro Cobo-Calvo, Sandra Vukusic, Romain Marignier
Pageof 22